Cocrystal Pharma, Inc. cotiza a 1.09 USD y tiene una capitalización bursátil de $21M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, su…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.17 | $-0.17 | $-0.19 | $-0.20 |
| Estimado | $-0.15 | $-0.17 | $-0.21 | $-0.30 |
| Sorpresa | -13.3% | +0.0% | +9.5% | +33.3% |
| Métrica | COCP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -139.5% | -40.4% | -99.1% |
| ROA | -90.9% | -32.0% | -58.9% |
| Current Ratio | 3.68 | 2.84 | +0.84 |
| Debt / Equity | — | 0.28 | — |